WEBULL
Releases
BNR
29.01
-3.04%
-0.91
  • All
  • Financials
  • Insiders
More
Webull provides the latest Burning Rock Biotech Ltd (BNR) stock and general news. This information may help you make smarter investment decisions.
About BNR
Burning Rock Biotech Ltd is a Company principally engaged in developing and providing cancer therapy selection tests. The Company operates three businesses, including central laboratory business, in-hospital business and pharma research and development services. Central laboratory business mainly includes the sales of its cancer therapy selection test to individual patient customers. In-hospital business includes the manufacture and sales of reagent kits, as well as the provision of facilitation services for laboratory equipment sold to hospitals. The pharma research and development services include a range of cancer therapy selection test services, analytical validation services and project management services.